IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on June 1, 2009
(Investigative Ophthalmology and Visual Science. )
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.08-2870

This Article
Right arrow Full Text (P<P[PDF])
Right arrow All Versions of this Article:
iovs.08-2870v1
50/6/2953    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimada, H.
Right arrow Articles by Kawashima, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimada, H.
Right arrow Articles by Kawashima, M.

Article

Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema

Hiroyuki Shimada 1*, Eriko Akaza 2, Mitsuko Yuzawa 2, and Miwako Kawashima 2

1 Ophthalmology, Nihon University, 1-8-13 Surugadai, Kanda, Chiyodaku, Tokyo, 101-8309, Japan
2 Ophthalmology, Nihon University, Tokyo, Japan

* To whom correspondence should be addressed. E-mail: sshimada{at}olive.ocn.ne.jp.


   Abstract

PURPOSE: We examined vascular endothelial growth factor (VEGF) concentrations in various regions of the vitreous in patients with diabetic macular edema (DME) to explore the possibility of a concentration gradient in the vitreous. METHODS: Vitreous samples were collected during vitrectomy from 71 eyes of 71 DME patients without posterior vitreous detachment who had not undergone panretinal photocoagulation. Vitreous samples were collected from the premacular vitreous and mid-vitreous (group A; 35 eyes), and from the premacular vitreous and peripheral cortical vitreous (group B; 36 eyes). Mean foveal thickness was measured by optical coherence tomography (OCT). Ten eyes of 10 patients with stage 3 macular hole (MH) served as controls. Vitreous VEGF levels were measured by enzyme-linked immunosorbent assay. RESULTS: The VEGF concentration (mean±standard deviation; pg/ml) was significantly higher in the premacular vitreous (1386.2±2134.1) than in the peripheral cortical vitreous (1169.7±1840.3; P=0.0216) and mid-vitreous (1080.9±1534.1; P=0.0017). The mean foveal thickness measured on OCT correlated significantly with VEGF concentrations in the premacular vitreous, peripheral cortical vitreous and mid-vitreous (R>0.62, P<0.0001, for all). In controls, VEGF concentrations in the premacular vitreous, peripheral cortical vitreous and mid-vitreous were all below the detection limit (<20 pg/ml). CONCLUSIONS: In DME, vitreous VEGF concentration correlates with mean foveal thickness measured on OCT. VEGF concentration was higher in premacular vitreous than in mid-vitreous and peripheral cortical vitreous, suggesting diffusion from the macular region to the periphery, and from the posterior to the anterior globe.

Key Words: diabetic retinopathy, cytokine, macular edema, optical coherence tomography, vitreoretinal surgery







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Association for Research in Vision and Ophthalmology